EWM
NVCR icon

Evercore Wealth Management’s NovoCure NVCR Stock Holding History

Evercore Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,200
Closed -$220K – 402
2018
Q3 		$220K Buy
+4,200
New +$167K 0.01% 391
2018
Q1 		– Sell
-2,700
Closed -$54K – 657
2017
Q4 		$54K Buy
+2,700
New +$52K ﹤0.01% 572

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Evercore Wealth Management's NVCR Position: Q4 2018 in Review

Evercore Wealth Management sold out of NovoCure (NVCR) in Q4 2018, closing a stake of 4,200 shares — an estimated $220K sold.

Evercore Wealth Management first reported a position in NVCR in Q4 2017 and held it in 2 quarters. The position peaked at $220K in Q3 2018. 166 funds tracked by Wall St. Rank hold NVCR as of Q4 2018.

  • Evercore Wealth Management reported no remaining NovoCure position as of Q4 2018 after selling out during the quarter.
  • Evercore Wealth Management sold 4,200 NovoCure shares in Q4 2018, an estimated $220K.
  • Evercore Wealth Management first reported a position in NovoCure in Q4 2017 and held it in 2 quarters.
  • Evercore Wealth Management's NovoCure position peaked at $220K in Q3 2018.
  • 166 funds tracked by Wall St. Rank held NovoCure as of Q4 2018.

Based on Evercore Wealth Management's 13F filing for Q4 2018, filed 13 Feb 2019.